Literature DB >> 14067470

REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE.

L HELLMAN, B ZUMOFF, G KESSLER, E KARA, I L RUBIN, R S ROSENFELD.   

Abstract

Entities:  

Keywords:  BUTYRATES; HYPERCHOLESTEREMIA; HYPERLIPEMIA

Mesh:

Substances:

Year:  1963        PMID: 14067470     DOI: 10.7326/0003-4819-59-4-477

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  THERAPY OF HYPERCHOLESTEROLEMIA.

Authors:  G A GOLDSMITH
Journal:  Am J Dig Dis       Date:  1964-09

2.  Effect of clofibrate on cholesterol metabolism in rats treated with polychlorinated biphenyls.

Authors:  M Nakagawa; T Shimokawa; A Noguchi; N Ishihara; S Kojima
Journal:  Lipids       Date:  1986-02       Impact factor: 1.880

Review 3.  Influence of sex on drug kinetics in man.

Authors:  J F Giudicelli; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

Review 4.  Experimental approaches to the prophylaxis and treatment of ischaemic heart disease.

Authors:  J D Fitzgerald
Journal:  Postgrad Med J       Date:  1971-01       Impact factor: 2.401

5.  Effect of atromid and its components on uric acid excretion and on gout.

Authors:  G Trevaks; R R Lovell
Journal:  Ann Rheum Dis       Date:  1965-11       Impact factor: 19.103

6.  Halofenate versus clofibrate in the management of true diabetes insipidus.

Authors:  A Gattereau; J Davignon; M Verdy; W Lewis
Journal:  Can Med Assoc J       Date:  1974-06-08       Impact factor: 8.262

7.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

8.  Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

Authors:  G G Duncan; F A Elliott; T G Duncan; J Schatanoff
Journal:  Trans Am Clin Climatol Assoc       Date:  1968

9.  A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

Authors:  P B Lazarow; C De Duve
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.